Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
BioLineRx Ltd. (BLRX) had Debt to Capital Ratio of 0.22 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$0.43M |
|
$-0.98M |
|
$0.08M |
|
$0.34M |
|
$2.63M |
|
$-2.21M |
|
$1.23M |
|
$-0.98M |
|
$-0.98M |
|
$-0.98M |
|
$-0.98M |
|
$-0.98M |
|
$-0.98M |
|
$-2.21M |
|
$-2.09M |
|
4.34M |
|
4.34M |
|
$0.00 |
|
$0.00 |
|
| Balance Sheet Financials | |
$28.52M |
|
$0.17M |
|
$11.28M |
|
$39.80M |
|
$13.67M |
|
$5.60M |
|
$6.60M |
|
$20.27M |
|
$19.53M |
|
$9.14M |
|
$19.53M |
|
4.35M |
|
| Cash Flow Statement Financials | |
$-4.87M |
|
$-8.21M |
|
$10.14M |
|
$10.44M |
|
$7.91M |
|
$-2.52M |
|
$0.35M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.09 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.22 |
0.52 |
|
80.33% |
|
-516.86% |
|
-516.86% |
|
-- |
|
-228.81% |
|
-228.81% |
|
$-4.87M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
0.04 |
|
0.61 |
|
147.33 |
|
-5.00% |
|
-10.68% |
|
-2.45% |
|
-3.89% |
|
$4.49 |
|
$-1.12 |
|
$-1.12 |
|